Ericka M. Ebot

1.9k total citations · 2 hit papers
36 papers, 1.2k citations indexed

About

Ericka M. Ebot is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Ericka M. Ebot has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 19 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Ericka M. Ebot's work include Prostate Cancer Treatment and Research (22 papers), Cancer, Lipids, and Metabolism (17 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Ericka M. Ebot is often cited by papers focused on Prostate Cancer Treatment and Research (22 papers), Cancer, Lipids, and Metabolism (17 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Ericka M. Ebot collaborates with scholars based in United States, Sweden and Ireland. Ericka M. Ebot's co-authors include Lorelei A. Mucci, Kathryn M. Wilson, Claire H. Pernar, Massimo Loda, Edward L. Giovannucci, Stephen P. Finn, Travis Gerke, Jennifer R. Rider, Thomas U. Ahearn and Andreas Pettersson and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Cancer Research.

In The Last Decade

Ericka M. Ebot

33 papers receiving 1.2k citations

Hit Papers

The Epidemiology of Prostate Cancer 2018 2026 2020 2023 2018 2023 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Epidemiology of Prostate Cancer
    2018 536 citations Claire H. Pernar, Ericka M. Ebot et al. profile →
  2. Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation
    2023 75 citations Smruthy Sivakumar, Jay A. Moore et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ericka M. Ebot United States 15 598 413 401 310 105 36 1.2k
Paul Toren Canada 19 681 1.1× 425 1.0× 272 0.7× 228 0.7× 58 0.6× 77 1.2k
Makoto Matsushita Japan 17 256 0.4× 485 1.2× 207 0.5× 256 0.8× 75 0.7× 47 956
Wederson M. Claudino United States 11 221 0.4× 491 1.2× 305 0.8× 345 1.1× 113 1.1× 17 1.1k
Dapeng Wu China 24 307 0.5× 903 2.2× 421 1.0× 481 1.6× 128 1.2× 88 1.8k
Russell Petty United Kingdom 18 361 0.6× 498 1.2× 173 0.4× 389 1.3× 57 0.5× 65 1.3k
Shin Yup Lee South Korea 23 654 1.1× 790 1.9× 397 1.0× 493 1.6× 174 1.7× 143 1.7k
Philipp Schatz Germany 16 247 0.4× 725 1.8× 337 0.8× 317 1.0× 101 1.0× 24 1.2k
Hui‐Ping Hsu Taiwan 24 293 0.5× 695 1.7× 384 1.0× 489 1.6× 130 1.2× 67 1.5k
Takehiko Segawa Japan 18 642 1.1× 600 1.5× 225 0.6× 190 0.6× 65 0.6× 61 1.3k

Countries citing papers authored by Ericka M. Ebot

Since Specialization
Citations

This map shows the geographic impact of Ericka M. Ebot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ericka M. Ebot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ericka M. Ebot more than expected).

Fields of papers citing papers by Ericka M. Ebot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ericka M. Ebot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ericka M. Ebot. The network helps show where Ericka M. Ebot may publish in the future.

Co-authorship network of co-authors of Ericka M. Ebot

This figure shows the co-authorship network connecting the top 25 collaborators of Ericka M. Ebot. A scholar is included among the top collaborators of Ericka M. Ebot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ericka M. Ebot. Ericka M. Ebot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, Debra L., Júlia C.F. Quintanilha, Natalie Danziger, et al.. (2024). Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice. Clinical Cancer Research. 30(20). 4644–4653. 5 indexed citations
2.
3.
Sivakumar, Smruthy, Jay A. Moore, Meagan Montesion, et al.. (2023). Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation. Cancer Discovery. 13(7). 1572–1591. 75 indexed citations breakdown →
4.
Sharaf, Radwa, Dexter X. Jin, John P. Grady, et al.. (2023). A pan-sarcoma landscape of telomeric content shows that alterations in RAD51B and GID4 are associated with higher telomeric content. npj Genomic Medicine. 8(1). 26–26. 5 indexed citations
5.
Madison, Russell W., Jay A. Moore, Dexter X. Jin, et al.. (2023). A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer. The Oncologist. 28(8). 691–698. 11 indexed citations
6.
Stopsack, Konrad H., Xiaofeng A. Su, Rebecca E. Graff, et al.. (2022). Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions. Molecular Cancer Research. 21(1). 14–23. 7 indexed citations
7.
Ebot, Ericka M., Daniel Duncan, Khaled Tolba, et al.. (2022). Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapy. npj Precision Oncology. 6(1). 44–44. 15 indexed citations
8.
Chalmers, Zachary R., Michael C. Burns, Ericka M. Ebot, et al.. (2021). Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2–ERG fusions. Prostate Cancer and Prostatic Diseases. 24(2). 558–566. 14 indexed citations
9.
Imada, Eddie L., Diego F. Sánchez, Wikum Dinalankara, et al.. (2021). Transcriptional landscape of PTEN loss in primary prostate cancer. BMC Cancer. 21(1). 856–856. 22 indexed citations
10.
Allott, Emma H., Ericka M. Ebot, Konrad H. Stopsack, et al.. (2019). Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer. Clinical Cancer Research. 26(5). 1086–1093. 43 indexed citations
11.
Tsang, Sabrina H., Sarah C. Markt, Amparo G. Gonzalez‐Feliciano, et al.. (2018). Association between Trichomonas vaginalis and prostate cancer mortality. International Journal of Cancer. 144(10). 2377–2380. 18 indexed citations
12.
Stopsack, Konrad H., Ericka M. Ebot, Mary K. Downer, et al.. (2018). Regular aspirin use and gene expression profiles in prostate cancer patients. Cancer Causes & Control. 29(8). 775–784. 1 indexed citations
13.
Graff, Rebecca E., Thomas U. Ahearn, Andreas Pettersson, et al.. (2018). Height, obesity, and the risk of TMPRSS2:ERG -defined prostate cancer. DSpace@MIT (Massachusetts Institute of Technology). 3 indexed citations
14.
Zelić, Renata, Valentina Fiano, Ericka M. Ebot, et al.. (2018). Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality. Prostate Cancer and Prostatic Diseases. 22(2). 284–291. 5 indexed citations
15.
Pernar, Claire H., Ericka M. Ebot, Andreas Pettersson, et al.. (2018). A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG. European Urology. 76(1). 33–40. 32 indexed citations
16.
Sinnott, Jennifer A., Kathryn M. Wilson, Ericka M. Ebot, et al.. (2018). Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency. European Urology. 74(5). 545–548. 4 indexed citations
17.
Ebot, Ericka M., Travis Gerke, David P. Labbé, et al.. (2017). Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer. Cancer. 123(21). 4130–4138. 9 indexed citations
18.
Ebot, Ericka M., Travis Gerke, David P. Labbé, et al.. (2017). Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer. DSpace@MIT (Massachusetts Institute of Technology).
19.
Kelly, Rachel S., Jennifer A. Sinnott, Jennifer R. Rider, et al.. (2016). The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study. Cancer & Metabolism. 4(1). 22–22. 26 indexed citations
20.
Ahearn, Thomas U., Andreas Pettersson, Ericka M. Ebot, et al.. (2015). A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. JNCI Journal of the National Cancer Institute. 108(2). djv346–djv346. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Toren Breakdown of academic impact, for papers by Makoto Matsushita Breakdown of academic impact, for papers by Wederson M. Claudino Breakdown of academic impact, for papers by Dapeng Wu Breakdown of academic impact, for papers by Russell Petty Breakdown of academic impact, for papers by Shin Yup Lee Breakdown of academic impact, for papers by Philipp Schatz Breakdown of academic impact, for papers by Hui‐Ping Hsu Breakdown of academic impact, for papers by Takehiko Segawa
Rankless by CCL
2026